Compare Amphastar Pharmaceuticals Inc (AMPH) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Alliant Energy Corporation — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Alliant Energy Corporation trades at $76.4 (market cap $19.73B). The key difference: Alliant Energy Corporation is far larger — about 23.9× Amphastar Pharmaceuticals Inc's market cap, and Alliant Energy Corporation pays a 2.73% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | LNT | |
|---|---|---|
Market Cap | $826.08M | $19.73B |
Sector | Health | Utilities |
52-Week High | $30.81 | $78.03 |
52-Week Low | $16.87 | $61.85 |
Enterprise Value | $1.22B | $31.45B |
Dividend Yield | — | 2.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
LNT trades at $76.40, up 0.92% today, with a bullish technical signal and mixed earnings history including a recent Q1 2026 beat. The company shows steady revenue growth to $4.36B in 2025 and a net margin of 18.58%, supported by a $13.4B investment plan and data center demand. Analysts are split with a 52% buy rating and a $75.67 consensus target, while the stock pays a $0.54 dividend.
Outlook is positive due to strategic investments and sector tailwinds, but risks include rising debt levels and interest rate sensitivity. The stock offers growth and income appeal, though investors should monitor execution on capital expenditures and competitive pressures in the utility space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
